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ABSTRACT
TRIM proteins contribute to selective autophagy, a process whereby
cells target specific cargo for autophagic degradation. In a previously
reported screen, TRIM17 acted as a prominent inhibitor of bulk
autophagy, unlike the majority of TRIMs, which had positive roles.
Nevertheless, TRIM17 showed biochemical hallmarks of autophagy-
inducing TRIMs. To explain this paradox, here, we investigated how
TRIM17 inhibits selective autophagic degradation of a subset of
targets while promoting degradation of others. We traced the
inhibitory function of TRIM17 to its actions on the anti-autophagy
proteinMcl-1, which associateswith and inactivates Beclin 1. TRIM17
expression stabilized Mcl-1–Beclin-1 complexes. Despite its ability to
inhibit certain types of selective autophagy, TRIM17 promoted the
removal of midbodies, remnants of the cell divisionmachinery that are
known autophagy targets. The selective loss of anti-autophagy Mcl-1
from TRIM17–Beclin-1 complexes at midbodies correlated with the
ability of TRIM17 to promote midbody removal. This study further
expands the roles of TRIMs in regulating selective autophagy by
showing that a single TRIM can, depending upon a target, either
positively or negatively regulate autophagy.
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INTRODUCTION
Autophagy is mechanism of cellular waste elimination involving
the delivery of cytoplasmic targets, including protein aggregates,
damaged organelles and pathogens, to the lysosome for degradation
(Khaminets et al., 2015; Lazarou et al., 2015; Gomes and Dikic,
2014; Pampliega et al., 2013). In the most-studied form of
autophagy, macroautophagy, the cytoplasmic cargo is sequestered
within a double-membrane delimited organelle termed an
autophagosome, which then fuses with lysosomes, resulting in the
degradation of its luminal contents (Mizushima et al., 2011). As
autophagy plays numerous key homeostatic functions in the cell, its
misregulation can be detrimental to cellular health, and both
insufficient and excessive autophagy have been shown to contribute
to various pathological states (Fulda and Kogel, 2015; Mizushima
and Komatsu, 2011).
Because of the cellular need to optimize autophagic activity, the
autophagy pathway is subject to extensive regulation (Popelka and
Klionsky, 2015). Signals regulating autophagy initiation, the stage
at which the initial membrane rearrangements take place that lead to
autophagosome formation, converge on the human VPS34 (also
known as PIK3C3) complex (Mizushima et al., 2011). This
complex generates phosphatidylinositol 3-phosphate (PI3P) on
membranes at sites of autophagosome biogenesis (Kihara et al.,
2001), leading to the recruitment of other components of the
autophagy machinery (Obara et al., 2008; Dooley et al., 2014). The
key regulatory component of the complex in mammalian cells is
Beclin 1 (Liang et al., 1999). Under autophagy ‘on’ conditions,
Beclin 1 is ubiquitylated on K63 (Shi and Kehrl, 2010) and/or
phosphorylated by the Ser/Thr kinases including MK2 and MK3
(also known as MAPKAPK2 and MAPKAPK3) (Wei et al., 2015),
AMPK (Kim et al., 2013) and ULK1 (Russell et al., 2013), the latter
of which is itself subject to positive or negative regulation by
upstream kinases such as AMPK or the mTOR complex (Kim et al.,
2011; Egan et al., 2011). In many cases, protein platforms facilitate
the interaction between Beclin 1 and its regulatory partners, as
exemplified by the exocyst, which brings ULK1 and Beclin 1
together during starvation-induced bulk autophagy (Bodemann
et al., 2011). Under autophagy ‘off’ conditions, Beclin 1 is held in
an inactive state through interactions with inhibitory binding
partners such as TAB2 (Criollo et al., 2011; Takaesu et al., 2012)
or certain members of the Bcl-2 family of proteins including Bcl-2
(Pattingre et al., 2005) and Mcl-1 (Tai et al., 2013; Germain et al.,
2011; Erlich et al., 2007). In addition to having roles in autophagy
initiation, Beclin 1 also contributes to the maturation of
autophagosomes into autolyosomes. This process is also regulated
at several levels, with at least some of the regulation again centered
on Beclin 1, as the interactions of Beclin 1 with UVRAG or Rubicon
respectively promote or inhibit maturation (Matsunaga et al., 2009;
Zhong et al., 2009). Autophagy is also regulated at a transcriptional
level by TFEB and other MiT or TEF transcription factors,
coordinating autophagy-inducing stimuli with the expression of
genes involved in autophagy or lysosome biogenesis (Settembre
et al., 2011), whereas the transcription factor ZKSCAN3 inhibits
their expression (Chauhan et al., 2013).
Another approach to autophagy regulation is at the level of
substrate specificity, whereby only selected targets are degraded. As
the result of intensive study, we are now beginning to understand
how the autophagic apparatus recognizes specific targets (Randow
and Youle, 2014). A general feature of this process is the presence of
receptors such as p62 (also known as sequestosome 1, SQSTM1)
that bridge the substrate to mammalian Atg8 homologs (mAtg8s),Received 31 March 2016; Accepted 13 August 2016
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such as LC3B (also known as MAP1LC3B), associated with the
autophagosomal membrane (Birgisdottir et al., 2013; Rogov et al.,
2014). Although our understanding of the players involved in
selective autophagy is growing, we know less about how the process
of selective autophagy is linked with autophagy regulation and how
some targets of selective autophagy are degraded while other
potential selective autophagy targets are spared.
Recent studies have implicated the TRIM family of proteins
(Reymond et al., 2001) as both autophagy receptors that directly
bind to their substrates (Kimura et al., 2015; Mandell et al., 2014;
Niida et al., 2010) and as autophagy regulators (Kimura et al., 2015;
Mandell et al., 2014; Barde et al., 2013; Yang et al., 2013), thus
potentially being positioned to couple target specificity with
autophagy induction or inhibition (Kimura et al., 2016). Several
TRIMs such as TRIM5α, TRIM6, TRIM20, TRIM21 and others
have been demonstrated to promote autophagy by assembling the
key autophagy regulators ULK1 and Beclin 1 in their activated
states (Kimura et al., 2015; Mandell et al., 2014). In contrast to these
autophagy-promoting TRIMs, TRIM17 (also known as Terf; testis
ring finger) is notable because its knockdown dramatically increases
the number of autophagosomes in cells, suggesting that TRIM17
can inhibit autophagy (Mandell et al., 2014). However, initial
investigations into the mode of action of TRIM17 unexpectedly
have indicated that it retains many characteristics of pro-autophagy
TRIMs including mAtg8 binding and organization of ULK1–
Beclin-1 complexes (Mandell et al., 2014). Here, we show that the
apparent dichotomy in TRIM17 autophagic actions result from it
having dual roles. TRIM17 protects a variety of selective autophagy
targets from degradation while also contributing to the elimination
of midbodies, known selective autophagy substrates consisting of
the tightly packaged remnants of the cell division machinery.
RESULTS
TRIM17 inhibits degradation of selective autophagy targets
We first tested how TRIM17 knockdown using multiple small
interfering RNAs (siRNAs) affected the abundance of p62 by
performing high-content imaging (Fig. 1A–C). We found that
TRIM17 siRNAs reduced the amount of total p62 (Fig. 1B) in HeLa
cells. Cells subjected to TRIM17 siRNAs also had fewer p62 puncta
(Fig. 1C), structures associated with polyubiquitylated protein
aggregates destined for autophagic degradation (Pankiv et al.,
2007). We also assessed the abundance of p62 and of the
autophagy-associated lipidated form of LC3B (known as LC3-II)
by immunoblotting (Fig. 1D). We again observed that the
abundance of p62 was reduced in TRIM17 knockdown cells
(Fig. 1E). Treatment of these cells with an inhibitor of
autophagosome maturation (bafilomycin A1) rescued the protein
levels of p62, indicating that TRIM17 expression reduces the
autophagic degradation of p62. TRIM17 knockdown did not
significantly affect the abundance of LC3-II (Fig. 1F). The effects of
TRIM17 knockdownwere independent of the stringency of the lysis
buffer used (Fig. 1G).
The above results indicate that TRIM17 inhibits the autophagic
degradation of p62. Accordingly, TRIM17 expression increased the
abundance of p62 structures in cells leading to, at times, a striking
aggregation of p62 (Fig. 1H). TRIM17 expression also prevented
p62 degradation in cells treated with pp242, a drug that induces
autophagy through mTOR inhibition (Fig. 1I). We next tested
whether TRIM17 could interfere with autophagic degradation of a
range of other reported targets for selective autophagy. Certain
proteins associated with primary ciliogenesis, including IFT20 and
OFD1, have been reported to undergo degradation by autophagy
(Pampliega et al., 2013; Tang et al., 2013). Accordingly, we found
that both IFT20 and OFD1 levels in cells were increased following
autophagy inhibition with bafilomycin A1 (Fig. 1J). When TRIM17
was expressed in these cells, IFT20 levels were similarly increased
and the effects of bafilomycin A1 on IFT20 levels were abrogated,
suggesting that TRIM17 prevents the selective autophagic
degradation of IFT20. We did not detect effects of TRIM17
expression on OFD1 or on ZWINT, another protein previously
reported to interact with TRIM17 (Endo et al., 2012). Additionally,
we did not detect an effect of bafilomycin treatment on the protein
levels of GFP–TRIM17, indicating that TRIM17 itself is not a target
of autophagy (Fig. 1I,J).
As another example of a selective autophagy target, we tested
whether TRIM17 could affect the autophagic targeting of TRIM5α,
which has recently been reported to be protected from lysosomal
degradation by autophagy inhibition (Imam et al., 2016). In
agreement with these findings, mCherry–eYFP–TRIM5α showed
primarily ‘red’ and not green fluorescence in cells, indicating its
presence within acidified compartments (Fig. 2A) (Klionsky et al.,
2016). Inhibition of autophagic maturation by bafilomycin
increased the signal from the pH-sensitive eYFP. We found that
TRIM17 was in protein complexes with TRIM5α in cells and also
co-immunoprecipitated TRIM22 (Fig. 2B), in keeping with the
previously reported observations that TRIM17 colocalizes with
TRIM5α and TRIM22 (Mandell et al., 2014). TRIM17 expression
reduced the colocalization between GFP–TRIM5α and LC3B
puncta (Fig. 2C), and GFP–TRIM5α and GFP–TRIM22 levels were
increased when co-expressed with mCherry–TRIM17 (Fig. 2D,E),
indicating that TRIM17 protects certain TRIMs from proteolysis.
In conjunction with the known anti-retroviral activities of
TRIM5α (Stremlau et al., 2004; Pertel et al., 2011), we have
reported that rhesus TRIM5α (RhTRIM5α) functions as an
autophagic receptor promoting degradation of the HIV-1 capsid
protein p24 (Mandell et al., 2014). Given that autophagy receptors
are typically co-degraded with their cargo (Johansen and Lamark,
2011), we reasoned that TRIM17-mediated protection of TRIM5α
might also protect p24 from autophagic degradation. Whereas
expression of GFP–RhTRIM5α in HEK293T cells reduced
the abundance of cellular p24 at 3 hours following infection with
VSV-G pseudotyped HIV-1 relative to cells expressing GFP alone
(Fig. 2F), co-expression of mCherry–TRIM17 prevented both
degradation of GFP–RhTRIM5α (as described above) and that of
HIV-1 p24 to levels exceeding those in cells expressing GFP alone.
Thus, TRIM17 expression blocked the RhTRIM5α- and autophagy-
dependent degradation of capsid protein. The observation that
TRIM17 increased levels of p24 above what was seen in control
cells (Fig. 2D, compare left and right lanes) suggests that additional
human proteins might act as receptors promoting autophagic
degradation of the HIV-1 capsid, although less efficiently than
RhTRIM5α. Collectively, these data show that TRIM17 is a broad,
albeit not universal, inhibitor of selective autophagy.
TRIM17 assembles Mcl-1–Beclin-1 complexes
We next sought to determine how TRIM17 interferes with
autophagy, and considered several possibilities. TRIM17 puncta
colocalized with the lysosomal marker LAMP2 (Fig. 3A). Under
autophagy ‘off’ conditions, TFEB localizes to lysosomes
(Settembre et al., 2012). Thus, we considered the possibility that
TRIM17 might suppress TFEB nuclear translocation to inhibit
autophagy. TRIM17 knockdown did not alter the nuclear
translocation of TFEB under basal or induced autophagy
conditions (Fig. 3B).
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Because TRIM5α and TRIM20 have been reported to
preferentially associate with the key autophagy regulator ULK1
in its active phosphorylated form (phosphorylated on Ser317)
(Kimura et al., 2015; Mandell et al., 2014), we next tested whether
TRIM17 preferentially bound to active or inactive (phosphorylated
on Ser757) phospho-ULK1. In these experiments, we also included
TRIM22, which we previously identified as a positive regulator of
autophagy (Mandell et al., 2014). Given the inhibitory effects of
TRIM17 on autophagy noted here, we were surprised to see that it
preferentially bound to active phospho-ULK1 (Fig. 3C) similar to
autophagy-promoting TRIMs. Thus, our experiments with TFEB
nuclear translocation or phospho-ULK1 do not help explain the
inhibitory effects of TRIM17 on autophagy.
BH3-domain proteins such as Bcl-2 can act to inhibit autophagy,
so we considered a model in which TRIM17 might inhibit
autophagy through actions on these proteins. TRIM17 has been
reported to interact with the Bcl-2 family protein Mcl-1 (Magiera
et al., 2013), a protein with known anti-autophagy functions that are
Fig. 1. TRIM17 expression reduces selective autophagy. (A) Representative epifluorescent microscopy image from high-content imaging analysis of p62
(green) in HeLa cells subjected to TRIM17 siRNA (siTRIM17) or scramble control siRNA (siScr). White lines indicate automatically determined cell boundaries.
(B) Left, knockdown efficiency of TRIM17 assessed by qPCR following transfection with different siRNA oligonucleotides. Right, the average intensity of anti-p62
signal per cell as determined by high-content imaging following control or TRIM17 knockdowns in HeLa cells. Data are means±s.e.m., n=3 experiments. *P<0.05
(ANOVAwith Bonferroni post hoc test). (C) Quantification of the average number of p62 puncta per cell as determined by high-content imaging following control or
TRIM17 knockdowns in HeLa cells. Data are means±s.e.m., n=3 experiments. *P<0.05 (ANOVA). (D–F) Effect of TRIM17 knockdown on the levels of LC3-II and
p62. (D) Immunoblot analysis of the abundance of the indicated proteins following TRIM17 or control knockdown and culture in the presence or absence of
bafilomycin A1 (BafA1) in full medium conditions. Quantification of relative p62 (E) or LC3-II abundance (F) as determined by densitometry. Data are means±
s.e.m., n=3 experiments. *P<0.05; †P>0.05 (ANOVA). (G) Cells were treated as in D prior to lysis under more stringent conditions (RIPA buffer). (H) High-content
imaging analysis of the effects of GFP–TRIM17 expression on the abundance of p62-positive structures. Cells were automatically identified based on
nuclear staining, and then cells showing above-background levels of GFP or GFP–TRIM17 fluorescence were analyzed for the total area of p62 structures (red)
per cell. White lines, cell boundaries. Purple structures in the right image indicate p62-positive structures identified by automated image analysis. Data are
means±s.e.m., n=3 experiments. *P<0.05 (t-test). Scale bars: 10 μm. (I) Immunoblot analysis of the effect of TRIM17 expression on the abundance of p62 in cells
treated with the autophagy inducer pp242 in the presence or absence of bafilomycin A1. Values underneath the p62 row indicate the relative abundance
as determined by densitometry. (J) Effects of TRIM17 expression protects on IFT20, OFD1 and ZWINT protein levels. Lysates from HEK293T cells were
transfected with GFP or GFP–TRIM17 and subjected to the indicated treatments (Full, full medium; Starve, starvation medium; Baf, BafA1 treatment) for 2 h were
probed for the indicated proteins by immunoblotting. Numbers underneath the rows indicate the relative abundance as determined by densitometry.
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similar to those of Bcl-2 (Pattingre et al., 2005; Wei et al., 2008;
Chang et al., 2010). Mcl-1 is proposed to block autophagy through
binding to the BH3 domain of Beclin 1 in an inhibitory manner
(Erlich et al., 2007), but additional mechanisms have also been
reported (Lindqvist et al., 2014). We thus tested whether TRIM17
could recruit Mcl-1 into Beclin 1 complexes. In agreement with our
previous results showing that TRIM17 interacts with Beclin 1, we
found that the two proteins colocalized to various puncta within
cells (Fig. 3D). In contrast, tagged TRIM17 and Mcl-1 did not show
any spatial association in colocalization studies (Fig. 3E), with
Mcl-1 showing a predominantly diffuse pattern in contrast to the
pattern of small puncta and large structures shown by TRIM17.
However, when TRIM17, Mcl-1, and Beclin 1 were all
co-expressed in cells, Mcl-1 was recruited into TRIM17–Beclin-1
puncta (Fig. 3F), suggesting that Beclin 1 might contribute to the
formation of TRIM17–Mcl-1 complexes, a model that we tested by
co-immunoprecipitation (Fig. 4A,B). Although we could detect
Mcl-1–TRIM17 protein complexes in cells, the addition of
exogenous Beclin 1 expression increased the abundance of these
complexes. Similarly, TRIM17 expression increased the interaction
between Mcl-1 and Beclin 1 (Fig. 4C,D). Taken together, these data
show that TRIM17 serves as an assembly platform for Beclin 1 with
its negative regulator Mcl-1.
We next tested whether Mcl-1 was important for TRIM17-
dependent p62 accumulation. As expected, cells transfected with
control siRNA and expressing GFP–TRIM17 had more p62-
positive structures relative to cells expressing GFP alone (Fig. 4E).
When Mcl-1 expression was knocked down by siRNA, GFP–
TRIM17 was attenuated in its ability to increase the abundance of
these p62 structures. These data indicate that the TRIM17-
interacting partner Mcl-1 contributes to the anti-autophagy
activities of TRIM17.
Fig. 2. TRIM17 inhibits autophagic degradation of TRIM5α and HIV-1 capsids. (A) TRIM5α is subject to lysosomal degradation. Tandem-fluorescence
mCherry–eYFP-tagged TRIM5α (tfRhTRIM5α; rhesus) yields primarily red fluorescence when expressed in HeLa cells. Bafilomycin A1 (Baf) restores YFP
fluorescence by inhibiting autolysosomal acidification. (B) Co-immunoprecipitation (IP) analysis of interactions between TRIM17 and other TRIMs from lysates of
transfected HEK293T cells. (C) Confocal microscopic analysis of colocalization between GFP–TRIM5α and endogenous LC3B in HeLa cells transfected with
mCherry–TRIM17 or mCherry alone. Insets show enlargements of the indicated area. Right, the Pearson’s correlation coefficient (colocalization) was determined
from confocal micrographs using image analysis software. Data are means±s.e.m., n=3 experiments. *P<0.05 (t-test). (D,E) Effect of TRIM17 expression on
protein levels of GFP-tagged RhTRIM5α (D) or TRIM22 (human; E). Numbers underneath the rows indicate the relative abundance of GFP–TRIM as determined
by densitometry. (F) Effect of TRIM17 expression on RhTRIM5α-dependent HIV-1 capsid protein (p24) degradation. HEK293T cells were transfected as
indicated and infected with VSV-G pseudotyped HIV-1 for 3 h under conditions of amino acid starvation (EBSS) prior to sample lysis. Numbers underneath the
p24 row indicate the relative abundance of p24 as determined by densitometry.
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TRIM17 promotes midbody removal by autophagy
Despite negatively regulating the degradation of several autophagy
targets, in some respects TRIM17 has features suggestive of a
positive-acting role in autophagy. These include (1) direct binding
to a subset of mAtg8s and p62 (Mandell et al., 2014), and (2) the
ability to assemble ULK1 and Beclin 1 into a complex (Mandell
et al., 2014), with the ULK1 interacting with TRIM17 being
preferentially in its active phospho-form (Fig. 3C). We found that a
subset of TRIM17 structures colocalize with punctate substrates
positive for p62 (Fig. 5A) and ubiquitin (Fig. 5B). These structures,
which are removed from cells by autophagy (Pankiv et al., 2007),
have an aggregate-like appearance in electron microscopy studies
(Bjorkoy et al., 2005). Accordingly, ultrastructural analysis of
TRIM17-demarcated cytoplasmic regions with correlative light
electron microscopy showed that TRIM17 localized to such
aggregates (Fig. 5C). Finally, a subset of TRIM17 structures
colocalized with the autophagosome marker LC3B (Fig. 6A),
suggesting further that TRIM17 might also positively affect
autophagy under some circumstances, possibly in a substrate-
dependent manner.
In a search for such putative targets, we considered the midbody
ring. Midbodies are dense protein structures containing the
remnants of the cell division machinery. They are formed at the
site of abscission and are inherited by one of the two daughter cells.
Previous studies (Isakson et al., 2013; Kuo et al., 2011; Pohl and
Jentsch, 2009) have shown that midbodies colocalize with LC3B,
with the autophagy receptors p62 and NBR1, and with the
autophagy adaptor ALFY (also known as WDFY3). Knockdown
Fig. 3. TRIM17 and Beclin 1 colocalize with the anti-autophagy factor Mcl-1. (A) Confocal microscopic analysis of the GFP–TRIM17 and LAMP2 localization
in HeLa cells. Arrows indicate colocalizing puncta. (B) High-content imaging analysis of TFEB nuclear translocation. Left, representative image of HeLa cells
subjected to TRIM17 knockdown (siTRIM17.1), treated with pp242, and stained to detect TFEB andDNA. The bottom image shows the cell boundary (whites line)
and TFEB-positive nuclei (yellow line). Right, the percent of nuclei showing TFEB-positivity under the indicated conditions. siScr, scrambled siRNA. Data are
means±s.e.m., n=3 experiments. †P>0.05 (ANOVA). (C) Co-immunoprecipitation (IP) analysis of interactions between TRIMs and active (pSer317) versus
inactive (pSer757) phospho-ULK1 from the lysates of transfected HEK293T cells as assessed by western blotting (WB). (D) Confocal microscopic analysis of the
GFP–TRIM17 and FLAG–Beclin-1 localization in HeLa cells. Arrows indicate colocalizing puncta. (E) Confocal microscopic analysis of the GFP–TRIM17 and
FLAG–Mcl-1 localization in HeLa cells. (F) Confocal microscopic analysis of the mCherry–TRIM17, Beclin-1–GFP and FLAG–Mcl-1 localization in transfected
HeLa cells. Arrows indicate colocalizing puncta. Enlargements of the indicated area in A, D E and F are shown on the right of the main images.
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of these proteins or the autophagy factors Beclin 1 or ATG7 led to
an accumulation of midbodies, demonstrating that their removal is
autophagy dependent. Similar to the above autophagy factors,
TRIM17 colocalized with or formed rings around midbodies
(recognized here with an antibody against MKLP1, a protein highly
concentrated in midbodies; Fig. 6B). We next used high-content
imaging to determine what effect TRIM17 knockdown had on the
abundance of midbodies (Fig. 6C–F). We found that cells subjected
to TRIM17 knockdown contained more midbodies regardless of the
TRIM17 siRNA used (Fig. 6D) and that the average size of the
midbodies in these cells was larger (Fig. 6E), both indicative of less
midbody degradation in the absence of TRIM17. Repeating these
experiments in cells stably expressing GFP-tagged MKLP1 yielded
similar results (Fig. 6F).
The number of midbodies per cell is dependent in part on the
duration of the cell cycle (Pohl and Jentsch, 2009), as midbodies are
only generated at the end of cytokinesis. We therefore tested
whether the observed effects of TRIM17 knockdown on midbody
numbers could be an indirect result of increased midbody
production resulting from TRIM17 accelerating the cell cycle. By
assessing the DNA content of TRIM17 knockdown cells, we found
that a higher percentage of TRIM17 knockdown cells were in S and/
or G2 phase than cells transfected with control siRNA (Fig. 6G).
Thus, TRIM17 promotes cell division, and its knockdown would be
expected to decrease, not increase, the number of midbodies per
cell, ruling out the indirect explanation. We also tested to see
whether TRIM17 knockdown altered the formation of midbodies at
the abscission site, but did not see any effect (Fig. 6H). Taken
together, these results show that TRIM17 contributes to the
autophagy-dependent removal of midbodies.
TRIM17 and Beclin 1 localize to midbodies, but Mcl-1 is
excluded
Given the inhibitory effect of TRIM17 on the degradation of other
autophagy targets, we wondered how TRIM17 could promote
the autophagic degradation of midbodies. As was the case with
Fig. 4. TRIM17 stabilizes interactions between autophagy factor Beclin 1 and anti-autophagyMcl-1. (A,B) Co-immunoprecipitation (IP) analysis of the effect
of Beclin 1 expression on the abundance of Mcl-1 in TRIM17 protein complexes from lysates of transfected HEK293T cells using anti-FLAG (for Mcl-1; A) or anti-
GFP (for Beclin 1; B) antibodies for immunoprecipitation. (C,D) Co-immunoprecipitation analysis of the effect of TRIM17 expression on the abundance of
Mcl-1 in Beclin 1 protein complexes from lysates of transfected HEK293T cells using anti-GFP (for Beclin 1; C) or anti-FLAG (for Mcl-1; D) antibodies for
immunoprecipitation. (E) Effect of Mcl-1 knockdown on the abundance of p62 puncta in cells expressing GFP alone or GFP–TRIM17. Top, knockdown efficiency
of Mcl-1 in HeLa cells. Bottom, HeLa cells were subjected to control (siScr) or Mcl-1 siRNA (siMcl-1) and subsequently transfected with GFP alone or
GFP–TRIM17. Fixed samples were stained with anti-p62 prior to automated imaging and analysis. Only cells showing GFP-positivity were analyzed. Data are
means±s.e.m., n=5 experiments. *P<0.05; †P>0.05 (ANOVA).
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TRIM17, we found that Beclin 1 also colocalizes with a population
of midbodies (Fig. 7A), and that mCherry–TRIM17, Beclin-1–GFP
and the midbody marker MKLP1 all colocalized (Fig. 7B). In
contrast, we were unable to find instances of FLAG-tagged Mcl-1
colocalizing with MKLP1 (Fig. 7C). Because our previous results
indicated that the localization pattern of Mcl-1 is altered when co-
expressed with both TRIM17 and Beclin 1, we also tested whether
FLAG-tagged Mcl-1 colocalized with MKLP1 in cells
simultaneously expressing GFP-tagged Beclin 1 and TRIM17 by
performing confocal microscopy (Fig. 7D,E). As expected, in these
cells, Mcl-1 had a punctate localization pattern, with Mcl-1 puncta
showing robust colocalization with the GFP signal. However,
although we readily found instances of GFP-positive midbodies,
these were Mcl-1 negative. Furthermore, we were unable to find any
Mcl-1 positive midbodies by confocal microscopy. To quantify
these relationships, we used high-content imaging to determine the
fraction of midbodies positive for GFP signal (TRIM17 and/or
Beclin 1) and Mcl-1 (Fig. 7F). We found that a substantially higher
percentage of midbodies were associated with TRIM17 and/or
Beclin 1 than with Mcl-1. These data suggest a model in which the
presence or absence of Mcl-1 determines whether TRIM17
complexes inhibit or promote selective autophagy.
Finally, we considered whether the autophagic removal of
midbodies might involve other TRIMs or if this function is specific
to TRIM17. To address this, we performed an siRNA screen in
which we knocked down a set of 35 TRIMs in HeLa cells and then
quantified the number of midbodies per cell by high-content
imaging (Fig. 8A,B). As expected, knockdown of autophagy factors
LC3B or Beclin 1 increased the number of midbodies per cell. In
contrast, and opposite to the effects of TRIM17 knockdown, a high
percentage of the TRIM knockdown cells had a reduced the number
of midbodies. Three TRIMs stood out at the other end of the
spectrum (TRIM21, TRIM47 and TRIM76, the latter is also known
as CMYA5) by increasing the number of midbodies per cell bymore
than three standard deviations above what was seen in cells
subjected to non-targeting siRNA. These data suggest that other
TRIMs, in addition to TRIM17, contribute to midbody abundance,
possibly through effects on the cell cycle as initially considered for
TRIM17 above (e.g. the majority of TRIMs tested), whereas the
autophagic removal of midbody remnants from cells following
cytokinesis might be the function of TRIM17 and possibly of
TRIM21, TRIM47 and TRIM76.
DISCUSSION
The purpose of our study was to determine the role of TRIM17
in autophagy, prompted by the previously reported features of
TRIM17 (Mandell et al., 2014) that are indicative of both
autophagy-promoting and autophagy-inhibiting activities. The
principal findings reported here are that TRIM17 inhibits
autophagic degradation of diverse known targets, but that at the
same time it focuses autophagy on at least one substrate,
midbodies. Its autophagy-inhibitory activities involve Mcl-1,
which TRIM17 assembles into complexes with the key
autophagy regulator Beclin 1. When TRIM17 carries out pro-
autophagy activities it is freed from Mcl-1, thus disinhibiting
autophagy at defined places.
Midbodies are organelles consisting of the multiple proteins
involved in the final steps of cytokinesis, which form at the
abscission site and are inherited by one of the two daughter cells.
These structures might not be inert, but instead appear to contribute
to cellular signaling and affect differentiation, with cells containing
elevated numbers of midbodies having more stem cell
characteristics (Dionne et al., 2015). Previous studies have shown
that autophagy contributes to midbody removal (Isakson et al.,
2013; Kuo et al., 2011; Pohl and Jentsch, 2009), collectively
indicating that midbodies colocalize with markers of the
autolysosomal system (e.g. LC3 proteins) and that knockdowns of
autophagy factors (ATG7 or Beclin 1) or receptors (p62, NBR1 and
Fig. 5. TRIM17 colocalizes with autophagic
substrates. (A) Confocal microscopic analysis of the
localization of GFP–TRIM17 and endogenous p62 in
HeLa cells. Arrows indicate colocalizing puncta.
(B) Confocal microscopic analysis of the localization
of GFP–TRIM17 and endogenous ubiquitin in HeLa
cells. Arrows indicate colocalizing puncta. Insets show
enlargements of the indicated area. (C) Correlative-
light electron microscopic analysis of GFP–TRIM17-
expressing HeLa cells. The boxed area indicates the
location of TRIM17 fluorescence.
3568
RESEARCH ARTICLE Journal of Cell Science (2016) 129, 3562-3573 doi:10.1242/jcs.190017
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
ALFY) can cause midbody accumulation. TRIM17 has the potential
to link these separate autophagy-related systems together along with
the autophagy-activating kinase ULK1 in its active form, consistent
with the concept of ‘precision autophagy’ proposed for other
TRIMs (Kimura et al., 2016). In addition to TRIM17, we identified
three other TRIMs (TRIM21, TRIM47 and TRIM76) that also
contribute to the autophagic removal of midbodies. TRIM21 (Niida
et al., 2010; Kimura et al., 2015) and TRIM76 (Mandell et al., 2014)
have been previously linked to autophagy, but little is known about
the physiological roles of TRIM47. Nevertheless, these
observations indicate a strong association between TRIMs and the
control of midbody abundance.
To date, the study of selective autophagy has focused primarily
on how presumptive targets of autophagy are identified by
receptors that guide the autophagic apparatus to explain how the
cell ‘decides’ what to degrade (Stolz et al., 2014; Rogov et al.,
Fig. 6. TRIM17 contributes to midbody degradation through autophagy. (A) Confocal microscopic analysis of GFP–TRIM17 and LC3B localization in HeLa
cells. Arrowheads indicate colocalizing puncta. (B) Colocalization analysis of GFP–TRIM17 and the midbody marker MKLP1 in HeLa cells. Insets show
enlargements of the indicated area. (C,D) High-content microscopic analysis of the effects of TRIM17 knockdown on midbody abundance. Midbodies were
detected in HeLa cells subjected to control (siControl) or TRIM17 knockdown with two separate siRNAs (siTRIM17) and stained with anti-MKLP1 and
automatically imaged and analyzed. Top, control siRNA. Bottom, TRIM17 siRNA. Images display machine-determined positions of cell boundaries (white lines)
and midbodies (yellow mask). The average number of midbodies per cell was then automatically determined (D). (E) The average size of midbodies was
determined in HeLa cells subjected to control or TRIM17 knockdown. (F) HeLa cells stably expressing GFP–MKLP1 were subjected to TRIM17 or control
knockdown, and the number of GFP-labeled midbodies per cell was determined by high-content imaging. (G) DNA content of HeLa cells subjected to TRIM17
or control siRNA as determined by propidium iodide staining and flow cytometry. Values shown in G represent the percentage of cells in G2 or S phase. Data,
means±s.e.m., n≥3 experiments. *P<0.05 (t-test). (H) Localization of midbodies in dividing cells following control or TRIM17 knockdown. HeLa cells were
transfected with the indicated siRNA 72 h prior to fixation and labeled for immunofluorescence with the indicated antibodies. Cells undergoing division were
identified on the basis of their nuclear morphology and the presence of a tubulin demarcated bridge that links the two daughter cells.
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2014). Our study suggests that another facet of selective
autophagy involves the cell selecting not to degrade certain
potential targets. We found that the inhibitory activities of
TRIM17 extended to blocking precision autophagy mediated by
other TRIMs, as exemplified by its ability to prevent TRIM5α-
dependent degradation of HIV-1 capsids. In addition to the
interactions between TRIM17 and several TRIMs (TRIM5α and
TRIM22) shown here, TRIM17 has also been reported to interact
with TRIM44 (Urano et al., 2009). TRIM17 binding to other
TRIM family members could similarly interfere with their pro-
autophagy functions, thus protecting their cognate substrates from
degradation and extending the substrate-protective repertoire of
Fig. 7. Mcl-1 is excluded from midbody-localized TRIM17 complexes, and other TRIMs contribute to midbody removal. (A) Confocal microscopic image
showing localization of Beclin-1–GFP to midbodies demarcated by anti-MKLP1 staining in HeLa cells. (B) Zoomed-in confocal image of a midbody showing
Beclin-1–GFP and mCherry–TRIM17 positivity. (C) Confocal images of a HeLa cell expressing FLAG-tagged Mcl-1 and stained with anti-MKLP1. (D) Confocal
microscopic colocalization analysis of Mcl-1 with midbodies in cells expressing GFP–TRIM17 and Beclin-1–GFP. Arrowhead, localization of midbody. Arrows,
puncta showing colocalization between GFP signal and FLAG-Mcl-1. Insets in A and C, and right panels of D show enlargements of the indicated area.
(E) Fluorescence intensity profile of midbody shown in D. (F) High content microscopic analysis of cells as in D showing the percentage area of midbodies
colocalizing with GFP signal (Beclin 1 and/or TRIM17) or Mcl-1 signal. Data are means±s.e.m., n=5 experiments. *P<0.05 (t-test).
Fig. 8. An siRNA screen reveals that additional TRIMs contribute to midbody degradation. (A,B) siRNA screen for TRIMs affecting midbody abundance.
HeLa cells stably expressing GFP–MKLP1 were subjected to the indicated knockdowns (siControl, control siRNA; siLC3B, LC3B siRNA; siTRIM21, TRIM21
siRNA; siTRIM76, TRIM76 siRNA) and the number of midbodies per cell was determined by high-content imaging at 72 h after transfection. Images in A display
machine-determined positions of cell boundaries (white lines) andmidbodies (yellowmask). Numbers in plot in B (black triangles) are TRIM gene numbers. Black
squares, LC3B or Beclin 1 (Bec). Open circles, cells subjected to control siRNA. Dashed lines, three standard deviations (s.d.) above or below mean of controls.
One of two experiments is shown.
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TRIM17. TRIM17 might not be the only TRIM that can focus
selective autophagy. We identified TRIM76 as contributing to
midbody removal. Like TRIM17, TRIM76 was also previously
identified as a negative regulator of autophagy (Mandell et al.,
2014). Furthermore, TRIM28 (also known as KAP1) has been
shown to promote autophagy in two studies (Barde et al., 2013;
Yang et al., 2013), yet it is also reported to act in an inhibitory
manner (Pineda et al., 2015). In the case of TRIM28, its
autophagy-modulating functions appear tied to its E3 ubiquitin
ligase activity – a feature shared with most TRIMs. The role of the
enzymatic activity of TRIM17, and how it contributes to
autophagy control vis-à-vis proteasomal actions, would be of
interest to future studies. Given their dual actions in autophagy
regulation, TRIM17, TRIM28, TRIM76 and potentially other
TRIMs could confer upon the cell an ability to discriminate
between autophagic substrates in a ‘this-but-not-that’ manner,
allowing for another layer of specificity in cytoplasmic quality and
content control by autophagy.
TRIM17 impacts upon cellular functions in additional ways.
First, we observed that TRIM17 regulates cell division, possibly
through its interactions with ZWINT (Endo et al., 2012). ZWINT
is a component of the kinetochore that is also reported to interact
with Beclin 1, although this has not been linked to autophagy
(Fremont et al., 2013). Second, we found that the inhibitory
actions of TRIM17 on autophagy led to p62 accumulation, and
p62 has been shown to affect numerous signaling pathways
(Katsuragi et al., 2015). A very recent report shows that these
signaling events can be affected by the actions of a TRIM upon
p62: TRIM21-dependent ubiquitylation of p62 interferes with the
ability of p62 to aggregate and sequester Keap1, a negative
regulator of cellular responses to oxidative stress (Pan et al., 2016).
TRIM17 expression increases the abundance of p62 aggregates,
and so would be expected to have an opposing effect to that of
TRIM21.
In conclusion, our study demonstrates a newmechanismwhereby
a TRIM regulates selective autophagy by promoting the autophagic
targeting of some substrates while blocking the targeting of others.
These dual and opposing activities of TRIM17, and potentially
other TRIMs like TRIM76, might endow cells with enhanced
precision in terms of cargo selection.
MATERIALS AND METHODS
Cells and viruses
HeLa and HEK293T (from the ATCC) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% fetal calf serum. Single
cycle HIV-1 was generated by co-transfection of plasmids encoding the
NL43 genome lacking the env gene and VSV-G protein into HEK293T
cells. HeLa cells stably expressing GFP–MKLP1 were cultured in the above
medium supplemented with 500 μg ml−1 G418.
Plasmids, siRNA and transfection
TRIM17 andMcl-1 were PCR amplified from commercially available cDNA
clones and recombined into pDONR221 using the BP reaction (Life Tech)
prior to being recombined into pDest expression plasmids by LR cloning. All
siRNA smart pools were from Dharmacon except siRNA TRIM17.2 and
TRIM17.3, which were purchased from Qiagen. With the exception of the
siRNA transfections for theTRIMscreen (with siRNApre-printed into the 96
well plates and transfected using Dharmafect reagent), siRNAwas delivered
to cells by nucleoporation (Amaxa). Sequence information for siRNA is
found in Table S1. Plasmid transfections were performed by either CaPO4 or
nucleoporation (Amaxa). All other plasmids have been described previously
(Mandell et al., 2014). Samples were prepared for analysis the day after DNA
transfection. For siRNA experiments, samples were prepared 48 h after
siRNA transfectionwith the exception of experiments assessing the effects of
knockdown on cell cycle or midbodies. These experiments were performed
72 h after transfection.
Infection and treatments
Transfected HEK293T cells were exposed to virus at 4°C for 1 h to allow
binding but not entry. Unbound virus was removed and bound virus was
allowed to infect cells under starvation-induced autophagy conditions
(EBSS) at 37°C for 3 h. Samples were then prepared for immunoblotting.
Working concentrations for inhibitors were as follows: pp242, 10 μg ml−1;
bafilomycin A1, 60 ng ml−1.
Quantitative RT-PCR
Cells were collected in RNALater (Qiagen, Valencia, CA). RNA was
isolated and purified using RNeasy kits (Qiagen) and cDNAwas generated
by using a high capacity cDNA reverse transcriptase kit with RNase
inhibitor and random hexamer primers (Applied Biosystems, Foster
City, CA) on a GeneAmp PCR System 9700 thermocycler (Applied
Biosystems). Quantitative real-time PCR (qPCR) was performed using an
ViiA 7 real-time PCR system with the Taqman Gene Expression master mix
(Applied Biosystems) and a Prime Time Predesigned qPCR Assay for
Trim17 (Integrated DNA technologies, Coralville, IA). Gene expression
was quantified using ViiA 7 QuantStudio Software v1.2.4 (Applied
Biosystems) relative to the housekeeping gene Hprt. The probe
and primer set for Trim17 is as follows; probe 5′-/56-FAM/TCCTTCAC-
C/ZEN/TTGCCCTGCCA/3IAbkFQ/-3′ (Integrated DNA Technologies),
forward primer 5′-CTTCTCAAACTCCAGCACAATG-3′, reverse primer
5′-AGTACCTTCGGGAGCAGAT-3′. The probe and primer set for hprt is
as follows; probe 5′-/56-FAM/AGCCTAAGA/ZEN/TGAGAGTTCAAGT-
TGAGTTTGG/3IAbkFQ/-3′ (Integrated DNATechnologies), forward primer
5′-GCGATGTCAATAGGACTCCAG-3′, reverse primer 5′-TTGTTGTA-
GGATATGCCCTTGA-3′.
Immunoblotting, immunofluorescence microscopy and
co-immunoprecipitation
Most immunoprecipitation, immunofluorescent labeling and immunoblots
were performed as described previously (Kyei et al., 2009) using a NP-40-
based buffer to generate protein lysates. Where indicated, cell lysis was
performed with RIPA buffer containing 1% NP-40 and 0.1% SDS.
Antibodies used were against: Flag (Sigma), p62 (BD), ULK1 phospho-
Ser317 and phospho-Ser757 (Cell Signaling), GFP (Abcam), mCherry
(Abcam), Mcl-1 (Abcam), Bcl-2 (Abcam), IFT20 (Abcam), OFD1 (Sigma),
ZWINT (Pierce), actin (Abcam), ubiquitin (MBL), LC3B (Sigma and
MBL), c-Myc (Santa Cruz), TFEB (Cell Signaling), and MKLP1 (Santa
Cruz Biotechnology). Additional information about antibody usage is found
in supplementary information (Table S2). All densitomentric quantitation of
immunoblot signals was normalized to actin. Quantitative analysis of
colocalization from confocal micrographs was performed using Slidebook 6
software (Intelligent Imaging).
High-content imaging
All high-content experiments were performed on HeLa cells in a 96-well
plate format. Following the indicated treatments, cells were
immunofluorescently labeled. High-content imaging and analysis was
performed using a Cellomics HCS scanner and iDEV software (Thermo)
and >500 cells were analyzed per treatment in quadruplicate per experiment.
Cell outlines were automatically determined based on background nuclear
staining. For experiments determining the total abundance of p62, the
SpotDetector BioApp was used to measure total above-background
fluorescence per cell. For assays involving the quantitation of defined
puncta (e.g. p62 or midbodies) or determining the extent of colocalization,
the Colocalization BioApp was used. When necessary, GFP-positive cell
populations were selected as previously described (Mandell et al., 2014).
Flow cytometry
HeLa cells subjected to control or TRIM17 knockdown were culture
for 72 h prior to paraformaldehyde fixation, permeabilization with Triton-
X-100, RNAse A treatment and staining with propidium iodide
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(0.5 µg ml−1). Data was collected in the FL-2 channel using a BD FACScan
instrument.
siRNA screen of TRIMs for roles in midbody degradation
HeLa cells stably expressing GFP-tagged MKLP1 were cultured in 96-well
plates containing siRNA smart pools against a subset of human TRIMs (or
control siRNAs) and transfection reagent (Dharmacon). At 72 h after
plating, the cells were fixed with paraformaldehyde and stained with
Hoechst 33342. High-content imaging of was performed as described above.
Two separate experiments were carried out. TRIMs whose knockdowns
increased the number of midbodies per cell by >3 s.d. above the mean of
non-targeting siRNA controls in both experiments were considered hits.
Correlative-light electron microscopy
HeLa cells were transfected with GFP–TRIM17 and plated on gridded
dishes (Mattek) prior to fixation with 1.5% glutaraldehyde and 2%
paraformaldehyde. The location of GFP-positive cells on the grid was
then notated prior to post-fixation treatment with 1% osmium tetroxide,
dehydration with ethanol and resin embedding. Resin blocks were trimmed
to expose the area of interest, and 70–90-nm sections were cut with a
diamond knife, stained with uranyl acetate and lead citrate and examined
using a Jeol 1400EX transmission electron microscope.
Statistical analysis
Two-tailed t-tests or ANOVA with Bonferroni post hoc analysis were used
to test for statistical significance, which was taken as P<0.05 from three or
more independent experiments.
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